Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- NEDO Selects Technology Research Projects for Funding in 2001
January 21, 2002
- Use of Celera Genomics Database Expanding in Japan
January 21, 2002
- Pharmacy-based Pharmacists Show Sharp Increase: Medical Professional Survey
January 21, 2002
- Company Leaders Express Commitment to Reform: New Year Addresses
January 21, 2002
- Results of Survey on Clinical Studies Announced
January 21, 2002
- Meiji Seika to Concentrate on Infectious Diseases
January 21, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 21, 2002
- Kirin's Pharma Business Policy for FY2002 Announced
January 21, 2002
- Saitama Drugstore Chain Greencross-coa to Acquire Ikeno
January 21, 2002
- 2002 to Be an Exciting Year: Mr Bessho of Suzuken
January 21, 2002
- Ain Pharmaciez: Sales, Profits Show Double-digit Increases
January 21, 2002
- BDJ: BD Eclipse, Needles to Reduce Needle Stick Injuries
January 21, 2002
- Suzuken to Create New MS Image Using IT
January 21, 2002
- Hyogo's Drugstore Chain Maruzen Aims at Sales of \40 Bil.
January 21, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 14, 2002
- IFN to Be Re-priced Next April
January 14, 2002
- Suntory, Sankyo Codevelop Glucagon-like Peptide-1 as Antidiabetic
January 14, 2002
- Ceiling of Copayment for the Elderly Decided
January 14, 2002
- Standard Format for Package Inserts for Medical Devices Issued
January 14, 2002
- Social Security Benefits Up 4.0% to \75.04 Trillion
January 14, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…